Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Caspase 3 pseudogene 1 (CASP3P1) is classified as a pseudogene, an inactive genomic DNA sequence similar to the functional caspase 3 (CASP3) gene but incapable of producing a functional protein product[4]. In contrast to the true caspase 3 enzyme—which is a critical executioner protease in the apoptotic pathway and a target of drug discovery—CASP3P1 has no known protein-coding function or therapeutically relevant activity. There is no evidence that CASP3P1 is involved in disease, serves as a biomarker, or interacts with any drugs. Its biological relevance, if any, would be indirect, such as effects via non-coding RNA regulation, for which there is currently no published evidence specific to CASP3P1[4]. Note on correctness: The query refers to a pseudogene, not the functional caspase 3 enzyme (CASP3). Pseudogenes are not considered therapeutic targets unless there is exceptional evidence for a functional role—which is lacking for CASP3P1[4]. References to further distinguish from the functional target: - Functional caspase-3 (CASP3) is an executioner caspase essential to apoptosis[1][2]. - CASP3 is a drug target; CASP3P1, by contrast, has no such role[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Caspase 3 pseudogene 1 (CASP3P1).